| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Slavtcheff Craig | Chief R&D Officer | P.O. BOX 619100, DALLAS | Jeffrey S. McFall as Attorney-in-fact for Craig Slavtcheff | 02 May 2025 | 0001786727 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KMB | Restricted Share Units 5/01/2025 (w/dividends reinvested) | Award | $0 | +4,004 | $0.000000 | 4,004 | 01 May 2025 | Common Stock | 4,004 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. |
| F2 | The restricted share units vest 30 percent on each of the first and second anniversaries of the grant date and the remaining 40 percent on the third anniversary of the grant date. |